FDA Investigator William V Millar

William V Millar has conducted inspections on 53 sites in 3 countries as of 13 Nov 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
53
Last Inspection Date:
13 Nov 2019
Investigator Role:
FDA Investigator
Redica ID:
100008815
Countries of Inspections:
France, United States of America, India
FDA Investigators that have inspected at least one site in common with William V Millar:
Alanna L Mussawwir Bias, Alexandra M Cossi, Alice A Blair, Amir Alavi, Anastasia I Onuorah, Andrea A Branche, Andrea George, PhD, Andrei Perlloni, Andrew E Kay, Andrew K Haack, PhD, Andrew P Lin, Andrew W Harmon, Angel K Sandhu, Angela D Wise, Anh M Lac, Anita Narula, PhD, Anthony E Keller, RPh, Arsen Karapetyan, Art O Czabaniuk, Ashar P Parikh, Azza Talaat, Bapu R Gaddam, Barbara J Wilcox, PhD, Benny Y Gong, Bo Chi, PhD, Bonita S Chester, Breena L D'ambrogi, Brett W Podoski, Bruce D Broidy, Bryan L Mcguckin, Calvin B Koerner, Candace Y Gomez Broughton, Capri R Woolridge, Carl A Anderson, Carl Lee, Carole L Jones, Carolyn A Renshaw, Caryn M Mcnab, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Chengjiu Hu, Chloe Anne Leong, Christine M Parmentier, Christopher R Czajka, Claudia Mperez Kasmarski, Courtney R Bolton, Courtney R Warren, Cynthia J Lee, MS, Cynthia L Ford, Dandan Wang, PhD, Daniel J Roberts, Darlene B Almogela, Darren S Brown, David G Eng, Deborah K Richardson, Debra D Devlieger, Dena L Jacobs, Diane L Raccasi, Dipesh K Shah, Dogbeda F Mackenzie, Douglas A Campbell, Dr. Mark J Seaton, PhD, Dr. Monica D Cooper, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edna J Hidalgo, Eileen A Liu, Elaine S Chow, Elisabeth A Drevet, Elizabeth Juarez, Emily Shacter, Emmanuel Adu Gyamfi, PhD, Emmanuel O Kerry, Ephrem Hunde, PhD, Eric L Dong, BS, Erica R Pomeroy, Farhana Khan, Gabrielle J Swain, Gerald Feldman, Gerald M Feldman, PhD, Gillenwater, Guerlain Ulysse, Gunneet Kaur, Henry K Lau, Hung H Do, MS, Huy T Pham, James A Lane, James C Yee, James R Evans, Janice Wai, Jannifer L Degroot, Jazmine M Welcher, Jeanmaire Hryshko, Jeanne A Young, Jeanne Fringer, PhD, Jeanne J Thai, Jeffery A Hangartner, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer Crumb, Jennifer L Degroot, Jennifer L Johnson, Jeremy W Rotton, Joan T Briones, Joanne Hosting, Joel D Martinez, Joey V Quitania, John A Gonzalez, John A Liu, John Cheung, Jolanna A Norton, Jolene S Hedgecock, Jose A Lopez, Jose M Cayuela, Joseph A Seitz, III, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua P Wireman, Joshua S Hunt, Joslyn K Brunelle, PhD, Juan A Morales, Jude C Dikes, Juliane Kjung Lau, Karen D Phung, Karen L Robles, Karla J Gibler, Kathryn E King, Katie T Duong, Kawshalya Pathiraja, Keith O Webber, PhD, Keith Webber, PhD, Kendra A Biddick, Keren Arkin, Kevin Lee, Kevin P Foley, Kim Lthomas Cruse, Kin T Moy, Kouros Kangarli, Kristin M Abaonza, Kula N Jha, Lakisha M Williams, Lance Mde Souza, MBA, Larkin R Buckalew, Lata C Mathew, PhD, Laura Fontan, MS, Laurie Graham, Laurie P Norwood, Lawrence J Stringer, LCDR Jennifer H Rhyu, Linan Ha, PhD, Linda S Shook, Linh Tu, Lucila B Nwatu, Luella J Rossi, Luis A Solorzano, Lydia S Chan, Mabel M Lee, Macropolk, Maida Henesian (NMI), Makia P Dove, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Marcus F Yambot, Maria Cruz Fisher, Maria Estrella, Maridali Deleon Torres, Marie K Kinkade, Marion D Wimberly, Jr, Mariza M Jafary, Mark E Chan, Mark I Nakano, Marsha W Major, Marshalette O Edwards, Mary C Wall, Mary R Hole, Matthew R Clabeaux, Mcgrewp, Megan E Kulas, Meisha R Sampson, Meisha Waters, Melody M Ragasa Leong, Miah I Schneider, Michael O Skidmore, Michael S Call, Michael Shanks, MS, Michael T Cyrus, Michele L Obert, Michele Perry Williams, Michelle L Tripp, Michelle Rfrazier Jessen, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Milos Dokmanovic, PhD, Min Shanmabel Liu, Monica Commerford, PhD, Mra Davism, Mra Mcculloughj, Muoi N Hoang, Natalia Pripuzova, PhD, Navneet Kaur, Nayan J Patel, Ngoc B Kelsch, Nicholas L Hunt, Nicholas Obiri, PhD, Nicole Yuen, Nympha V Florendo, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Patrick E Gainer, Patty P Kaewussdangkul, Paula A Trost, Peter E Baker, Peter Kessler, PhD, Phung, Prabhu P Raju, Qing Joanna Zhou, PhD, Quynh H Strandberg, Randall J Plunkett, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Renee L Rice, PhD, Reyes Candau Chacon, PhD, Richard E Needham, Richard Ledwidge (nmi), PhD, Riley C Graham, Riley C Myers, PhD, Robert D Tollefsen, Rocio Guzman Velazquez, Ronald P Boyce, Rumany C Penn, PharmD, Russell K Riley, Ruth Moore, PhD, Sandra S Saniga, Sara H Gabel, Savannah E Samp, Scott N Lim, Serge L Beaucage, Sharon K Thoma, PharmD, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Shirley J Berryman, Sidney B Priesmeyer, Sixto M Mercado Rios, Sony Mathews, Stephanie A Slater, MS, Steven B Chiu, Steven D Kehoe, Steven J Branch, Stuart W Russell, Susanna E Ford, Thea C Grome, Thomas J Arista, Thomas N Adjabeng, Thomas R Withers, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiffany Chao, Timothy C Grome, Tracy Denison, PhD, Travelle D Mason, Truong Xuan Nguyen (Andy), Uduak M Inokon, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vebina K Sethi, Vi T Au, Vibhakar J Shah, PhD, Walden H Lee, Wayne L Jefferson, Willemsj, William J Weis, Yi Wang, PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yong Hu, Zachary A Bogorad, Zedong Dong

William V Millar's Documents

Publish Date Document Type Title
November, 2010 FDA 483 Response Allure Labs, Inc - Form 483R, 2010-12-12
March, 2009 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2009-03-20
May, 2010 FDA 483 Libby Laboratories, Inc - Form 483, 2010-05-03
May, 2011 FDA 483 Intersect ENT, INC. - Form 483, 2011-05-09
February, 2012 EIR Bausch Health Americas, Inc. - EIR, 2012-02-10
July, 2010 FDA 483 ASI Marketing Group, LLC - Form 483, 2010-07-22
July, 2010 FDA 483 Genesis Pharmaceutical, Inc. - Form 483, 2010-07-16
November, 2019 FDA 483 Portland Compounding Pharmacy LLC - Form 483, 2019-11-26
September, 2009 FDA 483 ASI Marketing Group, LLC - Form 483, 2009-09-11
January, 2011 FDA 483 Impax Laboratories, LLC. - Form 483, 2011-01-21
March, 2012 FDA 483 Impax Laboratories, LLC. - Form 483, 2012-03-28
January, 2012 FDA 483 Libby Laboratories, Inc - Form 483, 2012-01-18
February, 2010 FDA 483 Boehringer Ingelheim Fremont, Inc. - Form 483, 2010-02-25
November, 2010 FDA 483 Allure Labs, Inc - Form 483, 2010-11-22
July, 2009 EIR U.F. UNION INTERNATIONAL FOOD, INC. - EIR, 2009-07-24
July, 2009 FDA 483 U.F. UNION INTERNATIONAL FOOD, INC. - Form 483, 2009-07-24
September, 2011 FDA 483 ABCO Laboratories, Inc - Form 483, 2011-09-09
February, 2012 FDA 483 Bausch Health Americas, Inc. - Form 483, 2012-02-10
December, 2011 FDA 483 Alexza Pharmaceuticals, Inc. - Form 483, 2011-12-12
March, 2011 FDA 483 AMPAC Fine Chemicals LLC - Form 483, 2011-03-04
June, 2012 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2012-06-15
September, 2011 FDA 483 Genentech, Inc. - Form 483, 2011-09-27
September, 2009 FDA 483 Genentech, Inc. - Form 483, 2009-09-28
May, 2013 FDA 483 Allure Labs, Inc - Form 483, 2013-05-24
September, 2024 FDA 483 Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483, 2024-09-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more